Zobrazeno 1 - 10
of 133
pro vyhledávání: '"E. Psachoulia"'
Publikováno v:
Poster Presentations.
Background The first etanercept biosimilar was approved by the European Commission in January 2016. Of the 27,000 patients* estimated to be treated with etanercept biosimilar in the Europe, 5,122 patients* are estimated to be on the etanercept biosim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abdbabd67d5f8f0c7a6da0ab6ae984b3
https://doi.org/10.1136/annrheumdis-2017-eular.3380
https://doi.org/10.1136/annrheumdis-2017-eular.3380
Autor:
Mihail Boyanov, Tzvetanka Petranova, Alexander Shinkov, E. Psachoulia, M. Intorcia, Reneta Petkova
Publikováno v:
Archives of Osteoporosis
Summary Persistence with osteoporosis therapy is critical for fracture risk reduction. This observational study evaluated medication-taking behaviour of women with postmenopausal osteoporosis receiving denosumab or oral ibandronate in real-world clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::860da493f84c5765f39a57a76b4702d4
https://pubmed.ncbi.nlm.nih.gov/29264666
https://pubmed.ncbi.nlm.nih.gov/29264666
Autor:
E Psachoulia, S Chouman
Publikováno v:
Value in Health. 20:A529-A530
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ef20c95af4abca3b3da8dc385e2ff00
https://doi.org/10.1016/j.jval.2017.08.743
https://doi.org/10.1016/j.jval.2017.08.743
Autor:
E. Psachoulia, C. Niedhart, Peter H. Kann, F. Thomasius, M. Intorcia, AA Kurth, M. Schulte, H. Schwarz, Peyman Hadji, J Kyvernitakis, L Hofbauer, T Schmid
Publikováno v:
Value in Health. 18(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef429a471df671df5200b957357d40bd
Autor:
E Psachoulia, V Casahorrán
Publikováno v:
Value in Health. 19:A533-A534
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a2529ebfea415fc98558fca384aef63
https://doi.org/10.1016/j.jval.2016.09.1088
https://doi.org/10.1016/j.jval.2016.09.1088
Autor:
A Bresson, E Psachoulia
Publikováno v:
Value in Health. 20:A529
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0223e8b0c14d4dff50487298c64006bf
https://doi.org/10.1016/j.jval.2017.08.740
https://doi.org/10.1016/j.jval.2017.08.740
Autor:
S Chouman, E Psachoulia
Publikováno v:
Value in Health. 20:A529
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a137602e6e0437574193eaccc3a05f2e
https://doi.org/10.1016/j.jval.2017.08.742
https://doi.org/10.1016/j.jval.2017.08.742
Autor:
E Psachoulia, S Keady
Publikováno v:
Value in Health. 20:A529
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a52f8f00d9a563fcda965e94ee56f5b
https://doi.org/10.1016/j.jval.2017.08.741
https://doi.org/10.1016/j.jval.2017.08.741
Publikováno v:
Value in Health. 17(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66c03aa3dc72205fd131eeeb864bbf13
Publikováno v:
Osteoporosis International
The Summary The objectives of this study were to estimate persistence with denosumab and put these results in context by conducting a review of persistence with oral bisphosphonates. Persistence with denosumab was found to be higher than with oral bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d624015d9ca00f73216b86d19b04799
https://pubmed.ncbi.nlm.nih.gov/26282229
https://pubmed.ncbi.nlm.nih.gov/26282229